[Effects on lipid metabolism of inhibitors of cholesterol synthesis].
Guarini
G
G
Costa
C
C
Trimarco
C
C
Santese
D
D
Vitaliano
E
E
D000368:Aged; D000924:Anticholesteremic Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D002994:Clofibrate / Q000494:pharmacology; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008148:Lovastatin / Q000494:pharmacology; D008297:Male; D008875:Middle Aged; D009525:Niacin / Q000494:pharmacology; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D008055:Lipids; D014280:Triglycerides; D009525:Niacin; D002784:Cholesterol; D008148:Lovastatin; D002994:Clofibrate
Sugli effetti lipometabolici di alcuni inibitori della sintesi del colesterolo.